Functional amyloid (FAs), particularly the bacterial proteins CsgA and FapC, have many
useful properties as biomaterials: high stability, efficient, and controllable formation of a …

Despite the recognized potential of nanoparticles, only a few formulations have progressed
to clinical trials, and an even smaller number have been approved by the regulatory …

Remarkable progress has been made in tumour immunotherapy in recent decades.
However, the clinical outcomes of therapeutic interventions remain unpredictable, largely …

Nanobiotechnology rapidly progresses to use nanostructures, improving the effectiveness of
cytotoxic agents for optimal anticancer results. In comparison to other nanostructures …